Zealand Pharma A/S (ZLDPF)
39.80
-17.87
(-30.99%)
USD |
OTCM |
Mar 06, 16:00
Zealand Pharma Cash from Investing (TTM) : -350.42M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Genmab A/S | -5.660B |
| Ascendis Pharma A/S | -9.612M |
| Bavarian Nordic A/S | -285.65M |
| ALK-Abello A/S | -60.00M |
| Evaxion AS | -- |